Stay updated on Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew help sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added; the Intervention/Treatment heading was reformatted and the revision footer updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check20 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a newer version of the study record. This reflects an update to the page metadata rather than any substantive changes to the study details.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows revision: v3.5.4, replacing the previous revision v3.5.3, indicating a standard update to the page version.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov revision version number (from v3.5.2 to v3.5.3). This appears to be a site software/update marker rather than a change to the trial’s information.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check99 days agoChange DetectedRecord history shows new Actual dates added (2026-03-13, 2025-12-05, 2026-03-10) and the revision updated to v3.5.0. Older entries (e.g., 2025-11-05, 2025-11-03, 2025-10) were removed.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.